Roche is the recipient of the new approval, getting the go-ahead from the US regulator for its PATHWAY HER2 (4B5) test to ...
Big Pharma often turns to NFL games to hawk their blockbuster treatments, but drug makers have typically been hesitant to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback